SII has collaborated with Oxford University and AstraZeneca for making the COVID-19 vaccine.
The Serum Institute was founded by Adar Poonawalla's father Cyrus Poonawalla in 1966.
SINGAPORE: Adar Poonawalla , the chief executive of the world's largest vaccine manufacturer Serum Institute of India, is among six people named "Asians of the Year" by Singapore's leading daily, The Straits Times for their work in fighting the COVID-19 pandemic.
Pune-based Serum Institute of India (SII) has collaborated with the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca for making the COVID-19 vaccine, ''Covidshield'', and is conducting trials in India.
The other five named in the list are Chinese researcher Zhang Yongzhen, who led the team that mapped and published online the first complete genome of Sars-CoV-2, the virus that sparked the pandemic, China's Major-General Chen Wei, Japan's Dr Ryuichi Morishita and Singapore's Professor Ooi Eng Eong, who are among those at the forefront of developing vaccines against the virus, and South Korean businessman Seo Jung-jin whose company will enable the making and dispensing of the vaccines and other Covid-19 treatments to the world.
Collectively referred to as "the virus busters", they are heroes of a kind, having devoted themselves to the pressing cause of resolving the coronavirus pandemic, each in their own capacity, the daily said.
"Sars-CoV-2, the virus that has brought death and hardship to the world's largest and most populous continent, is meeting its tamer in The Virus Busters," the award citation said.
"We salute your courage, care, commitment and creativity. In this peril-filled hour, you are a symbol of hope for Asia, indeed the world."
The Serum Institute was founded by Poonawalla's father Cyrus Poonawalla in 1966.
Poonawalla joined the Serum Institute of India in 2001 and became the CEO of Serum Institute with complete control of the day-to-day operations of the company in 2011.
Poonawalla said that he has put USD 250 million of his family fortune into ramping up his institute's manufacturing capacity.
"I decided to go all out," said Poonawalla, 39, who has pledged that his firm's COVID-19 vaccines will help supply lower- and middle-income countries that face significant disadvantages in the quest to obtain them.
Poonawalla said his institute is helping poorer countries level up in access to vaccines.
In the big picture of ending the pandemic, commonality of purpose is key, said The Straits Times, Singapore's mainstream daily.
The Straits Times Asians of the Year have led the way, as have scores of other individuals in their own fields. When an end comes into sight, it will be due in no small part to these people who - undaunted by the tumult - have committed themselves to the sobering, much-needed work to put together an exit plan from the crisis, for humanity.
"There has not been a day this year when the pandemic has not been in the news. Straits Times' editors felt there could be no more deserving recipients this year than the people squaring up to Asia's biggest-ever health challenge, engaged in pioneering and courageous efforts to prevent the highly contagious virus from wreaking more damage," Bhagyashree Garekar, Straits Times' foreign editor, said on Saturday.
"In a year that is ending with a wish for great resets... Asia's virus busters are the face of hope on the horizon," said Garekar.
Between them, the recipients of the 2020 award capture the entire trajectory of the response to the COVID-19 pandemic.
In deciding to honour The Virus Busters, Straits Times editors had in mind those who have, in one way or another, enabled the complex, multi-stage process of preventing as many people around the world from getting the deadly disease in as little time as possible.
"Each year, ST editors seek out a person, team or organisation that has not only made or shaped the news, but also helped contribute positively to Asia in the process," said Warren Fernandez, editor-in-chief of Singapore Press Holdings' English/Malay/Tamil Media Group and editor of Straits Times.
"This year, we naturally looked to those involved in the fight against Covid-19, which has dominated the headlines. We debated long and hard, but finally agreed on a group of people who have done the most to help find an answer to the crisis brought on by the virus.
"They are a disparate group whose collective efforts have pushed forward the search for vaccines, allowing these to be discovered and delivered with an urgency never attempted or seen before. Their commitment and actions have helped save lives and give hope to people all around Asia, and the world," Fernandez said.
Source - The Economic Times
Serum Institute Of India sends out Covishield vaccine - Consignment of Covishield Vaccine arrived in Delhi, Chennai, Kolkata, Guwahati, Shillong, Ahmedabad, Hydrabad, Vijayawada, Bhubaneswar, Patna, Bengaluru, Lucknow, Chandigarh
Serum Institute of India launches India’s first fully indigenously developed pneumococcal vaccine, 'PNEUMOSIL'
Oxford COVID-19 vaccine: Serum Institute likely to submit final Covishield trial data within 10 days
SII’s Adar Poonawalla on Covid vaccine, pricing and rollout at Hindustan Times Leadership Summit 2020
COVISHIELD Completes Enrolment of Phase III clinical trials under partnership of ICMR and Serum Institute of India
Government Secures Vaccine Supplies For Half Of The Indian Population From Serum Institute And Novavax
IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access
Serum Institute Of India Takes A Multipronged Approach In Quest To Produce World’s First Covid-19 Vaccines
Serum Institute of India to produce up to an additional 100 million covid 19 vaccine doses for india and low and midle income countries in 2021
Adar Poonawalla CEO of Serum Institute of India, the world’s largest vaccine manufacturer, explains the timing, challenges & cost of vaccinating the world against COVID-19
Serum Institute looking for a $1 billion shot to fight covid, talks on with Blackstone, KKR and others
Serum Institute of India Says Covid Vaccine Likely to Be Ready by End of 2020, Final Pricing in 2 Months
Serum institute of india to produce up to 100 million covid-19 vaccine doses for india and low-and middle-income countries as early as 2021
50% of our Covid vaccines will be for India, people won't have to buy them, govts will pay: Adar Poonawalla
AstraZeneca vaccine's success in early human trials, Will Begin AstraZeneca Vaccine Trial in India After Applying for Licence Next Week, Says Serum Institute
Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’
New supply agreement between UNICEF and Serum Institute of India makes pneumococcal conjugate vaccine available at US$2.00 per dose, a 43 % reduction from the Gavi price at the start of the Advance Market Commitment
Serum Institute confident of manufacturing Covid vaccine’s 100 million doses if trials establish efficacy
Serum Institute’s Journey To Success | ET NOW Covid-19 vaccine possible by Q2 of 2022: Adar Poonawalla
Adar Poonawalla discusses Serum Institute's progress in the global battle against COVID-19 with Shereen Bhan, CNBC-TV18
Adar Poonawalla talks with Aabha Bakaya about the success story of Serum Institute of India. Tune in to know all about the journey of the company.
Bill Gates confers Indian Council of Medical Research "Lifetime Achievement Medal" on Dr. Cyrus Poonawalla
Dr. Cyrus Poonawalla conferred with 'Lifetime Achievement Award’ by the Asian Business Leadership Forum
Dr. Cyrus Poonawalla conferred with the prestigious honorary degree by the University of Oxford, U.K.